国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01099 国药控股

未开盘 04-23 16:09:13

20.900

-0.100

-0.48%

最高21.100	最低20.600	成交量285.46万
今开21.000	昨收21.000	日振幅2.38%
总市值652.22亿	流通市值280.44亿	总股本31.21亿
成交额5,963万	换手率0.21%	流通股本13.42亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"国药控股","latestPrice":20.9,"timestamp":1713859753013,"preClose":21,"halted":0,"volume":2854571,"delay":0,"floatShares":1341810740,"shares":3120656191,"eps":3.1348975,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.1,"latestTime":"04-23 16:09:13","open":21,"high":21.1,"low":20.6,"amount":59625482,"amplitude":0.02381,"askPrice":20.95,"askSize":100800,"bidPrice":20.9,"bidSize":31200,"shortable":3,"etf":0,"ttmEps":3.134897435854039,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713922200000},"adr":0,"adjPreClose":21,"dividendRate":0.044928,"openAndCloseTimeList":[[1713835800000,1713844800000],[1713848400000,1713859200000]],"volumeRatio":0.47775526719765943,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK"},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"2429816888","title":"国药控股04月23日主力资金流入282万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2429816888","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429816888?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:16","pubTimestamp":1713860207,"startTime":"0","endTime":"0","summary":"04月23日, 国药控股股价跌0.48%，报收20.90元，成交金额5962万元，换手率0.21%，振幅2.38%，量比0.48。国药控股今日主力资金净流入282万元，连续3日净流入，上一交易日主力净流入772万元，今日环比减少63.47%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为42.11%，平均涨幅为1.14%。该股近5个交易日上涨6.45%，主力资金累计净流出428万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出2013万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042316174387a532b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042316174387a532b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429871181","title":"南向资金4月22日净买入国药控股70.83万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429871181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429871181?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:31","pubTimestamp":1713835869,"startTime":"0","endTime":"0","summary":"4月22日, 南向资金增持国药控股70.83万股，连续3日增持。截止当日收盘，港股通共持有国药控股18716.01万股，占流通股13.93%。国药控股近5个交易日上涨6.49%，港股通累计增持236.11万股；近20个交易日上涨1.69%，港股通累计增持106.36万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309455187a38741&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309455187a38741&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429318878","title":"国药控股主体信用评级获\"AAA/稳定\"，2022年营收5521.48亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429318878","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429318878?lang=zh_cn&edition=full","pubTime":"2024-04-23 07:26","pubTimestamp":1713828376,"startTime":"0","endTime":"0","summary":"2024年4月23日，中国货币网公布评级报告，中诚信给予国药控股2023年主体信用评级为“AAA/稳定”，评级展望“国药控股信用水平在未来12~18个月内将保持稳定”，评级日期为2024年4月22日。财务数据显示，2020年至2023年3月，国药控股营业收入分别为4564.15亿元、5210.51亿元、5521.48亿元和1455.18亿元，资产负债率分别为71.02%、70.21%、69.75%和71.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042307275487a31645&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042307275487a31645&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429523914","title":"国药控股04月22日获主力加仓772万元 环比增加721.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429523914","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429523914?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:16","pubTimestamp":1713773789,"startTime":"0","endTime":"0","summary":"04月22日, 国药控股股价涨5.63%，报收21.00元，成交金额1.49亿元，换手率0.53%，振幅6.54%，量比1.26。国药控股今日主力资金净流入772万元，上一交易日主力净流入94万元，今日环比增加721.28%。该股近5个交易日上涨5.22%，主力资金累计净流出1688万元；近20日主力资金累计净流出2792万元，其中净流出天数为12日。该股主力净额占比0.03%，港股市场排名127/2628。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216170487a06efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042216170487a06efb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428683903","title":"大摩：予国药控股(01099)“增持”评级 目标价降至28港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428683903","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428683903?lang=zh_cn&edition=full","pubTime":"2024-04-19 14:28","pubTimestamp":1713508100,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研究报告称，下调国药控股(01099)目标价3.4%，从29港元降至28港元。对该公司2024-2030年盈利预测下调3%-6%，主要原因是药品分销的销售以及毛利率降低，但评级仍予“增持”，原因包括该公司作为国企，是唯一一家中央政府持有的药品经销商，在内地药品分销商中处于领先地位，具有全国规模，能够提供强大的安全网。大摩表示，对国药基本假设，是基于其领导地位、持续增长以及利息成本较低。2024-2025年收入和盈利实现高个位数增长，高出中国医疗保健行业水平3-5%。该公司融资成本稳定在收入的1%或以下。利润率也稳定，业务结构变动以及效率提升抵消降价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105233.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428573780","title":"恒生中国央企指数，股息率界的扛把子","url":"https://stock-news.laohu8.com/highlight/detail?id=2428573780","media":"鹏华基金","top":-1,"share":"https://www.laohu8.com/m/news/2428573780?lang=zh_cn&edition=full","pubTime":"2024-04-19 08:49","pubTimestamp":1713487792,"startTime":"0","endTime":"0","summary":"当前中证国企指数PE长期低于中证民企指数。成分股所属恒生一级行业分布股息率高于众多主流指数跟踪指数2023年股息率达7.05%，虽然不带“红利”二字，其股息率却高的惊人。可以发现，在一众红利指数中，其股息率名列前茅。相比于恒生指数PE值8.32，估值更低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419084744861e7273&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419084744861e7273&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428550299","title":"国药控股：国药新光4K除雾内窥镜系统获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2428550299","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2428550299?lang=zh_cn&edition=full","pubTime":"2024-04-18 17:23","pubTimestamp":1713432180,"startTime":"0","endTime":"0","summary":"证券时报e公司讯，据国药控股消息，4月16日，国药控股所属国药新光医疗科技有限公司自主研发的4K除雾内窥镜摄像系统、内窥镜LED光源正式获批北京市药监局颁发的医疗器械注册证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181724128b354911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181724128b354911&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427139158","title":"【券商聚焦】招银国际料今年中国医药行业有望回归健康增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2427139158","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2427139158?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:56","pubTimestamp":1713250565,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，年初至今，MSCI中国医疗指数下跌22.7%，跑输MSCI中国指数23.3%。展望2024年，随着行业监管常态化进行，新冠基数影响逐渐消退，中国医药行业有望回归健康增长。另外，行业监管仍呈现持续高压态势，预计院内刚需将在下半年出现需求复苏。该行认为，行业严格监管或将常态化，然而，诊疗秩序逐步正常，院内产品和服务的需求仍将保持健康。考虑到基数原因，该行预期行业或将于今年下半年加速增长。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/YjQxYWY4NjkyMTU2YjM4ZTVhNGFhMzYzNjE2NzgxMDU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935150","is_publish_highlight":false,"gpt_icon":0},{"id":"2427556638","title":"国药控股(01099.HK)拟4月26日举行董事会会议批准季度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2427556638","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2427556638?lang=zh_cn&edition=full","pubTime":"2024-04-16 07:49","pubTimestamp":1713224964,"startTime":"0","endTime":"0","summary":"格隆汇4月16日丨国药控股(01099.HK)发布公告，董事会将于2024年4月26日(星期五)举行董事会会议，藉以考虑及批准(其中包括)公司及其附属公司截至2024年3月31日止三个月的未经审核季度业绩。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-16/doc-inarynky6128280.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-16/doc-inarynky6128280.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427703094","title":"南向资金4月12日净卖出国药控股202.56万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427703094","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427703094?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:31","pubTimestamp":1713144672,"startTime":"0","endTime":"0","summary":"4月12日，南向资金减持国药控股202.56万股连续3日减持。截止当日收盘，港股通共持有国药控股18422.82万股，占流通股13.72%。港股通减持金额前五个股分别为腾讯控股、小鹏汽车-W、中国平安、汇丰控股、泡泡玛特。国药控股近5个交易日下跌2.80%，港股通累计减持498.80万股；近20个交易日下跌12.23%，港股通累计增持114.45万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150945238b23b6f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150945238b23b6f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426270992","title":"国药控股04月12日获主力加仓190万元 环比增加3066.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426270992","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426270992?lang=zh_cn&edition=full","pubTime":"2024-04-12 16:16","pubTimestamp":1712909802,"startTime":"0","endTime":"0","summary":"04月12日, 国药控股股价跌2.11%，报收19.44元，成交金额1.14亿元，换手率0.44%，振幅2.92%，量比1.17。国药控股今日主力资金净流入190万元，上一交易日主力净流入6万元，今日环比增加3066.67%。该股近5个交易日下跌3.00%，主力资金累计净流入802万元；近20日主力资金累计净流入2813万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121618028b15d253&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404121618028b15d253&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426233457","title":"宸汐健康完成超1亿元A轮融资，董事长李伟控股25.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426233457","media":"地产k线","top":-1,"share":"https://www.laohu8.com/m/news/2426233457?lang=zh_cn&edition=full","pubTime":"2024-04-10 17:22","pubTimestamp":1712740967,"startTime":"0","endTime":"0","summary":"瑞财经 刘治颖4月10日，国药控股旗下的健康管理和患者综合服务平台宸汐健康宣布完成超1亿元人民币A轮融资。目前，宸汐健康法定代表人为李伟，注册资本为2497.5882万元，经营范围包含：医学研究和试验发展；软件开发；网络与信息安全软件开发等。经股权穿透，董事长兼经理李伟为受益所有人，最终受益股份为25.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101730378b0931c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101730378b0931c3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426410356","title":"宸汐健康完成超1亿元A轮融资 国药控股加速打造新质生产力","url":"https://stock-news.laohu8.com/highlight/detail?id=2426410356","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2426410356?lang=zh_cn&edition=full","pubTime":"2024-04-10 09:25","pubTimestamp":1712712300,"startTime":"0","endTime":"0","summary":"证券时报e公司讯，4月10日，国药控股旗下的健康管理和患者综合服务平台宸汐健康宣布完成超1亿元A轮融资。本轮融资由上海国际集团资产管理有限公司领投，曜金资本和四川创新发展投资管理有限公司跟投。继2022年引入太平洋保险后，公司资本实力进一步加强，将继续加速业务拓展，巩固国药控股所打造的新质生产力生态版图。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410092608875d0039&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410092608875d0039&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426615984","title":"国药控股获FMR LLC增持99.76万股 每股作价约20.49港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426615984","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426615984?lang=zh_cn&edition=full","pubTime":"2024-04-09 16:20","pubTimestamp":1712650854,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，4月2日，FMR LLC增持国药控股（01099）99.76万股，每股作价20.4938港元，总金额约为2044.46万港元。增持后最新持股数目约1.62亿股，最新持股比例为12.04%。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-09/doc-inarfmtw2246018.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-09/doc-inarfmtw2246018.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426308871","title":"FMR LLC增持国药控股(01099)99.76万股 每股作价约20.49港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426308871","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426308871?lang=zh_cn&edition=full","pubTime":"2024-04-09 15:05","pubTimestamp":1712646353,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月2日，FMR LLC增持国药控股(01099)99.76万股，每股作价20.4938港元，总金额约为2044.46万港元。增持后最新持股数目约1.62亿股，最新持股比例为12.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099898.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426131838","title":"国药控股(01099)出现大手成交36.6万股，成交价$20.025，涉资732.915万","url":"https://stock-news.laohu8.com/highlight/detail?id=2426131838","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426131838?lang=zh_cn&edition=full","pubTime":"2024-04-09 14:11","pubTimestamp":1712643060,"startTime":"0","endTime":"0","summary":"[大手成交]国药控股(01099)在下午02:11出现大手成交，成交量为36.6万，成交价为港币$20.025，涉资732.915万。至目前为止，股价升1.317%，今日最高价为$20.25，而最低价为$19.64，总成交量为442.923万股，总成交金额港币$8.809千万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404092601/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2425959711","title":"国药控股04月08日遭主力抛售461万元 环比增加172.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425959711","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425959711?lang=zh_cn&edition=full","pubTime":"2024-04-08 16:15","pubTimestamp":1712564105,"startTime":"0","endTime":"0","summary":"04月08日, 国药控股股价跌1.30%，报收19.74元，成交金额1.10亿元，换手率0.41%，振幅3.30%，量比1.00。国药控股今日主力资金净流出461万元，连续6日净流出，上一交易日主力净流出169万元，今日环比增加172.78%。该股近5个交易日下跌3.53%，主力资金累计净流出1006万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入3886万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408161506875393d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408161506875393d0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425674397","title":"国药控股：国药一致2023年度净利润15.99亿元 同比增长7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425674397","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2425674397?lang=zh_cn&edition=full","pubTime":"2024-04-08 07:20","pubTimestamp":1712532031,"startTime":"0","endTime":"0","summary":"国药控股（01099）发布公告，该公司附属公司国药集团一致药业股份有限公司（国药一致）（000028.SZ）截至2023年12月31日止年度实现营业收入754.77亿元，同比增长2.77%；归属于上市公司股东的净利润15.99亿元，同比增长7.57%；归属于上市公司股东的扣除非经常性损益的净利润15.33亿元，同比增长7.58%；基本每股收益2.87元/股。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-08/doc-inaramre4496193.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-08/doc-inaramre4496193.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425211614","title":"国药控股(01099.HK)附属国药一致去年赚15.99亿人民币  增长7.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425211614","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425211614?lang=zh_cn&edition=full","pubTime":"2024-04-07 20:20","pubTimestamp":1712492400,"startTime":"0","endTime":"0","summary":"国药控股(01099.HK) 公布，附属国药一致(000028.SZ) 2023年度业绩，营业收入754.77亿人民币(下同)，按年增加2.8%。归属股东净利润15.99亿元，增长7.6%，每股收益2.87元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-05 16:25。) (A股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/22末期业绩普通股息：人民币 0.872023/10/27第三季业绩无派息2023/08/28中期业绩无派息2023/04/28第一季业绩无派息 AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180202161552248_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180202161552248_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1340454/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2425155566","title":"国药控股(01099)：国药一致(000028.SZ)2023年度净利润15.99亿元 同比增长7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425155566","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425155566?lang=zh_cn&edition=full","pubTime":"2024-04-07 18:47","pubTimestamp":1712486877,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药控股(01099)发布公告，该公司附属公司国药集团一致药业股份有限公司(国药一致)(000028.SZ)截至2023年12月31日止年度实现营业收入754.77亿元，同比增长2.77%;归属于上市公司股东的净利润15.99亿元，同比增长7.57%;归属于上市公司股东的扣除非经常性损益的净利润15.33亿元，同比增长7.58%;基本每股收益2.87元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099060.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":0.0696},{"period":"1month","weight":0.0121},{"period":"3month","weight":0.0965},{"period":"6month","weight":0.0784},{"period":"1year","weight":-0.2113},{"period":"ytd","weight":0.022}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":0.02},{"period":"3month","weight":0.0584},{"period":"6month","weight":-0.0127},{"period":"1year","weight":-0.1569},{"period":"ytd","weight":-0.0128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"国药控股股份有限公司主要从事药品及医疗器械分销业务。该公司通过三个业务分部运营。医药分销分部向医院、其他分销商、零售药店及诊所等客户分销药物、医疗器械及医药制品。医药零售分部从事经营医药连锁店业务。其他业务分部从事分销实验室用品、制造及分销化学试剂、以及生产和销售医药制品业务。该公司还通过其子公司在中国从事提供医药物流服务及从事物业租赁业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.002677},{"month":2,"riseRate":0.6,"avgChangeRate":0.035656},{"month":3,"riseRate":0.533333,"avgChangeRate":0.016144},{"month":4,"riseRate":0.466667,"avgChangeRate":0.026807},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.012667},{"month":6,"riseRate":0.357143,"avgChangeRate":-0.008776},{"month":7,"riseRate":0.5,"avgChangeRate":-0.010904},{"month":8,"riseRate":0.5,"avgChangeRate":0.015262},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.021807},{"month":10,"riseRate":0.666667,"avgChangeRate":0.048849},{"month":11,"riseRate":0.4,"avgChangeRate":-0.013864},{"month":12,"riseRate":0.533333,"avgChangeRate":-0.00596}],"exchange":"SEHK","name":"国药控股","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药控股,01099,国药控股股票,国药控股股票老虎,国药控股股票老虎国际,国药控股行情,国药控股股票行情,国药控股股价,国药控股股市,国药控股股票价格,国药控股股票交易,国药控股股票购买,国药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药控股(01099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药控股(01099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}